10-Q: Natural Health Trends Reports Q2 Sales Decline Amid China Trade Tensions

Natural Health Trends Corp. reported a 6% decrease in net sales for the second quarter of 2025, primarily driven by negative consumer sentiment in its key Hong Kong/China market due to escalating U.S.-China tariffs.

Summary

• Net sales for the three months ended June 30, 2025, decreased by 6% to $9.8 million, down from $10.5 million in the comparable period of 2024.
• Year-to-date net sales for the six months ended June 30, 2025, were $20.6 million, a 4% decrease from $21.4 million in the prior year.
• Hong Kong net sales, which primarily represent sales to members in China, decreased by 5% to $8.0 million for the quarter and 3% to $17.1 million year-to-date.
• Loss from operations increased to $333,000 for the quarter (from $238,000 in Q2 2024) and to $678,000 year-to-date (from $603,000 in YTD 2024).
• Net income significantly declined to $15,000 for the quarter (from $173,000 in Q2 2024) and to $137,000 year-to-date (from $361,000 in YTD 2024).
• Basic earnings per share (EPS) for the quarter was $0.00, down from $0.02 in Q2 2024, and $0.01 year-to-date, down from $0.03 in YTD 2024.
• Cash, cash equivalents, and marketable securities totaled $34.2 million as of June 30, 2025, a decrease of $9.7 million from December 31, 2024.
• Cash used in operating activities for the six months ended June 30, 2025, increased to $5.2 million, compared to $3.0 million in the prior year period.
• The company paid a final installment of $5.1 million for the repatriation tax on deferred foreign income in April 2025.
• Active members declined to 29,260 as of June 30, 2025, from 31,110 at June 30, 2024.
• Working capital decreased by $4.3 million to $25.9 million as of June 30, 2025.

Sentiment

Score: 3

Explanation: The company reported significant declines across key financial metrics including net sales, net income, and EPS, coupled with increased operating losses and cash used in operations. The core market (China/Hong Kong) is experiencing negative consumer sentiment due to ongoing trade tensions, which directly impacted Q2 sales. While the company maintains a strong liquidity position and continues dividends, the deteriorating operational performance and persistent geopolitical risks in its primary market indicate a negative outlook.

Positives

• Maintains a strong current ratio of 2.7 to 1.0, indicating solid short-term liquidity.
• Holds a substantial cash, cash equivalents, and marketable securities balance of $34.2 million.
• The Board of Directors declared a quarterly cash dividend of $0.20 per common share, with an expectation to continue this for the foreseeable future.
• Has $21.9 million remaining available under its $70.0 million stock repurchase program.
• Relocated its corporate headquarters from Hong Kong to California in February 2025, potentially mitigating some geopolitical risks associated with Hong Kong.
• Actively evaluating options to transition product manufacturing from the U.S. to other Asian jurisdictions to mitigate tariff impacts, which could lead to future savings in logistics, freight, and manufacturing costs.

Negatives

• Experienced a 6% year-over-year decline in net sales for the second quarter and a 4% decline for the first six months of 2025.
• Loss from operations increased for both the three-month and six-month periods compared to the prior year.
• Net income saw a significant decrease, falling from $173,000 to $15,000 for the quarter and from $361,000 to $137,000 year-to-date.
• Basic earnings per share dropped to $0.00 for the quarter and $0.01 year-to-date.
• Cash, cash equivalents, and marketable securities decreased by $9.7 million from the end of 2024.
• Cash used in operating activities increased by $2.1 million for the first six months of 2025.
• Working capital decreased by $4.3 million.
• The number of active members continued to decline, reaching 29,260 as of June 30, 2025, down from 31,110 a year prior.
• Commissions as a percentage of net sales increased, indicating higher payout ratios relative to revenue.

Risks

• Changes in government trade and economic policies, including the imposition of tariffs and other restrictive trade policies, particularly between the United States and China, which have already negatively impacted sales.
• Substantial portion of overall business derived from Hong Kong operations, with nearly all Hong Kong business from sales to members in China, making the company highly vulnerable to adverse changes in either region.
• Hong Kong's changing political and economic landscape due to increasing Chinese government influence could adversely affect future business.
• Negative operating cash flows experienced in recent years (2022, 2023, 2024) and only modest positive flows in 2020 and 2021, which could materially adversely affect the business and stock price if not improved.
• Adverse publicity associated with products, ingredients, or network marketing program could harm financial condition and operating results.
• Unfavorable economic and market conditions and the uncertain geopolitical environment may adversely affect business and financial performance.
• Risks relating to product concentration and lack of revenue diversification.
• Epidemics, natural disasters, terrorist attacks, or acts of war or hostility may seriously harm the business.
• High level of competition in the industry could adversely affect the business.
• Failure of new products to gain member and market acceptance could harm the business.
• Reliance on a limited number of independent third parties to manufacture and supply products on a timely basis.
• Growth may be impeded by political and economic risks of entering and operating in foreign markets.
• Failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act of 2002 could negatively impact the business and common stock price.
• Adverse effects from management changes or an inability to attract and retain key management, directors, and consultants.
• Continuing loss of a significant number of members is adversely affecting the business, and inability to stabilize or increase member count could further negatively impact the business.
• Improper member actions that violate laws or regulations could harm the business, despite members being independent contractors.
• An increase in the amount of compensation paid to members would reduce profitability.
• Potential responsibility for certain taxes or assessments relating to the activities of members and service providers.
• Business in China is subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations or government actions could have a material adverse impact.
• Direct-selling laws and regulations may prohibit or severely restrict direct sales efforts and cause revenue and profitability to decline, and new regulations could be adopted that harm the business.
• Subject to a variety of laws, regulations, and obligations regarding privacy, data protection, and information security, with non-compliance potentially materially adversely affecting the business.
• Challenges by third parties to the legality of business operations could harm the business.
• Past and potential future lawsuits, claims, and governmental proceedings and inquiries could harm the business.
• Currency exchange rate fluctuations could lower revenue and net income.
• Changes in tax or duty laws, and unanticipated tax or duty liabilities, could adversely affect net income.
• Transfer pricing regulations affect business and results of operations.
• Products and related activities are subject to extensive government regulation, which could delay, limit, or prevent product sales in some markets.
• New regulations governing the marketing and sale of nutritional supplements could harm the business.
• Regulations governing the production and marketing of personal care products could harm the business.
• Operations could be harmed if found not to be in compliance with good manufacturing practices.
• Failure to comply with domestic and foreign laws and regulations governing product claims and advertising could harm the business.
• Subject to anti-bribery laws, including the U.S. Foreign Corrupt Practices Act.
• Lack of a comprehensive product liability insurance program means product liability claims could hurt the business.
• May be unable to protect or use intellectual property rights.
• Reliance on and risks associated with information technology systems.
• System disruptions or failures, cybersecurity risks, and compromises of data, or failure to comply with related laws and regulations, could harm the business.
• Systems, software, and data residing on third-party servers expose the company to risks of disruption or intrusion.
• Common stock is particularly subject to volatility because of the industry and markets in which the company operates.
• Common stock continues to experience wide fluctuations in trading volumes and prices, making it difficult for holders to sell shares when desired and at attractive prices.

Future Outlook

The company expects to continue paying a quarterly cash dividend of $0.20 per common share for the foreseeable future, subject to Board discretion. It plans to continue investing in its Mainland China entity to establish manufacturing capabilities, increase brand awareness, source Chinese-made products, build service stations, open Healthy Lifestyle Centers or branch offices, and add local staffing, all in preparation for a prospective China direct selling license application. The company is actively evaluating options to transition production of certain products from the U.S. to other jurisdictions in Asia to mitigate the effects of tariffs, which may result in cost savings but also short-term expenses. The impact of trade policy changes on future quarters remains uncertain, as does the effect of general consumer sentiment in China. The company will also evaluate the impact of the newly enacted One Big Beautiful Bill Act (OBBBA) on its deferred tax balances for the third quarter of 2025.

Management Comments

• Our priority is to focus resources in our most promising markets, including Greater China, Southeast Asia, India, South America, and Europe, where existing members can recruit prospects and sell products.
• We believe our Hong Kong e-commerce direct selling platform and China e-commerce retail platform do not currently require a direct selling license in China, which we do not hold.
• We expect to reapply for a direct selling license in China when circumstances are again ripe for doing so, though we do not expect initial increased sales to be material and they may be offset by higher fixed costs.
• We are unable to predict whether and when we will successfully obtain a direct selling license in China, or if such operations would be profitable.
• Second quarter sales were negatively affected by negative consumer sentiment and economic uncertainty in our largest market due to the threat of reciprocal and retaliatory tariffs.
• If substantial tariffs remain in place, we may begin to see the effect of higher duties on restocking later this year and may need to impose a surcharge on products sold into China, which could further negatively affect sales volumes.
• In the longer term, we have taken initial steps to transition production of certain U.S.-manufactured products to other jurisdictions, including Asia, to mitigate tariff effects, potentially resulting in savings but also short-term expenses.
• We expect to continue paying a quarterly cash dividend of $0.20 on each share of common stock outstanding for the foreseeable future.
• Our existing internal liquidity, supported by cash on hand and cash flows from operations, should be adequate to fund normal business operations and address financial commitments for the foreseeable future, and we do not currently believe it will be necessary to generate more funding from capital markets.

Industry Context

Natural Health Trends Corp. operates in the international direct-selling and e-commerce sectors, focusing on personal care, wellness, and quality of life products. The industry is highly competitive and subject to extensive government regulation, particularly concerning direct selling activities and product claims. The company's significant reliance on the Greater China market exposes it to unique geopolitical and trade policy risks, as evidenced by the negative impact of U.S.-China tariffs on its second-quarter sales. The broader business environment in China for health product companies remains challenging, exacerbated by past government campaigns targeting illegal practices and negative social media sentiment.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess performance against global industry benchmarks.

Legal Proceedings

• No legal proceedings were reported.

Related Party Transactions

• The company has a Royalty Agreement and License with Broady Health Sciences, L.L.C. (BHS) for the manufacture and sale of the product ReStor. George K. Broady, a former director and beneficial owner of over 5% of the company's common stock, is an indirect owner of BHS. Lucy Nduati, a current director, serves other Broady-controlled companies.
• Royalties paid to BHS were $9,000 for the three months ended June 30, 2025 (compared to $10,000 in 2024) and $18,000 for the six months ended June 30, 2025 (compared to $19,000 in 2024).
• The agreement automatically renewed for an additional one-year term as neither party provided the required 90-day advance notice.

Stakeholder Impact

• Shareholders: Face declining net income and EPS, a decrease in total cash and marketable securities, and continued share price volatility. However, the company maintains a quarterly dividend and has an active stock repurchase program.
• Members: The number of active members continues to decline, which is a key operational metric for a direct-selling company. Commissions as a percentage of net sales increased, potentially benefiting active members.
• Customers: Negative consumer sentiment in China due to trade policies has impacted demand for products. Potential for future surcharges on products sold into China could further affect customer purchasing power.
• Employees: The corporate headquarters relocated from Hong Kong to California in February 2025, which may impact employees in both locations.

Next Steps

• Evaluate the impact of the One Big Beautiful Bill Act (OBBBA) on deferred tax balances for the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.
• Continue investing in the Mainland China entity for establishing China-based manufacturing capabilities, increasing public awareness of the brand and products, sourcing more Chinese-made products, building a chain of service stations, opening additional Healthy Lifestyle Centers or branch offices, and adding local staffing.
• Reapply for a direct selling license in China when circumstances are deemed 'ripe' for doing so.
• Actively evaluate options and take initial steps to transition production of certain products currently manufactured in the United States to other jurisdictions, including in Asia, to mitigate the effect of U.S. and reciprocal tariffs.
• Continue paying a quarterly cash dividend of $0.20 on each share of common stock outstanding for the foreseeable future, subject to Board discretion.

Key Dates

Recommendation

The filing reveals significant deterioration in Natural Health Trends Corp.'s core business performance, with declining net sales, increased operating losses, and a sharp drop in net income and EPS. The company's heavy reliance on the China market, which is currently experiencing negative consumer sentiment due to escalating U.S.-China trade tensions, poses a substantial and ongoing risk to revenue generation. The continued decline in active members further signals underlying weakness in the direct selling model. While the company maintains a strong balance sheet with ample cash and marketable securities, and continues its dividend, these positives are overshadowed by the negative operational trends and the unpredictable geopolitical environment impacting its primary revenue stream. The lack of clear positive catalysts for growth and the explicit acknowledgment of negative impacts from external factors suggest a challenging outlook, making the stock a 'sell' for seasoned investors.

Keywords

Direct Selling, E-commerce, Health Products, Wellness, Personal Care, China Market, Hong Kong Operations, Tariffs, Trade Policy, Network Marketing, SEC Filing, Quarterly Report, NHTC